Home > Signaling Pathways>Protein Tyrosine Kinase>c-MET>Capmatinib HCl hydrate (INCB-28060; INC280)
Capmatinib HCl hydrate (INCB-28060; INC280)

This product is for research use only, not for human use. We do not sell to patients.

Capmatinib HCl hydrate (INCB-28060; INC280)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$1200To Be Confirmed
500mg$1800To Be Confirmed
1g$2700To Be Confirmed

Cat #: V2201 CAS #: 1865733-40-9 Purity ≥ 98%

Description: Capmatinib HCl hydrate (INCB28060; INC-280) is a n FDA-approved, orally bioavailable, ATP-competitive inhibitor of c-MET (IC50 = 0.13 nM in a cell-free assay) with anticancer activity.

References: Liu X, et al. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. Clin Cancer Res. 2011 Nov 15;17(22):7127-38.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)503.36
Molecular FormulaC23H21Cl2FN6O2
CAS No.1865733-40-9
SMILES Code O=C(NC)C1=CC=C(C2=NN3C(N=C2)=NC=C3CC4=CC=C5N=CC=CC5=C4)C=C1F.[H]Cl.[H]Cl.[H]O[H]
SynonymsINCB28060; INCB-28060; INCB 28060; Capmatinib; Capmatinib hydrochloride; NVP-INC 280AAA; INC280; INC-280; INC 280; INCB028060; INCB-028060; INCB 028060;
ProtocolIn VitroCapmatinib (INCB28060) (0-333 nM; 24 h) induces apoptosis in SNU-5 cells. Capmatinib (INCB28060) (0.5-50 nM; 20 min) suppresses phosphorylation of both EGFR and HER-3 rapidly. Capmatinib (INCB28060) (0.24-63 nM; over night) prevents HGF-stimulated H441 cell migration. Capmatinib (INCB28060) (0.06-62.25 nM; 2h) effectively inhibits phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib (INCB28060) (0-10000 nM; 72 h) inhibits the proliferation of SNU-5, S114, H441 and U-87MG. Capmatinib (INCB28060) inhibits c-MET phosphorylation with an IC50 value of approximately 1 nM and a concentration of approximately 4 nM inhibits c-MET more than 90%, which is reversible and the effect is significantly reduced in several hours after the compound is removed and completely disappeared by 48 hours.
In VivoCapmatinib (INCB28060) (0.03-10 mg/kg; PO, single dosage) causes inhibition of c-MET phosphorylation in S114 tumor mice model. Capmatinib (INCB28060) (1-30 mg/kg; PO, twice daily, for 2 weeks) exhibits dose-dependent inhibition of tumor growth, and shows well tolerance at all doses during the treatment periods, with no evidence of overt toxicity or weight loss in U-87MG tumor mice model.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.9866 mL9.9332 mL19.8665 mL39.7330 mL
5mM0.3973 mL1.9866 mL3.9733 mL7.9466 mL
10mM0.1987 mL0.9933 mL1.9866 mL3.9733 mL
20mM0.0993 mL0.4967 mL0.9933 mL1.9866 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.